13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001425738
申报总市值
US$14.9亿
US$14.9亿
63 檔
34.1%
根据最新整理的 13F 季度数据集，Redmile Group, LLC 于 Q2 2024 结束时的管理资产规模为 US$14.9亿。该机构在本季度申报了 63 档美股持仓，呈现出该时期的主要投资地图。
在 Q2 2024，Redmile Group, LLC 展现出较为审慎的避险与获利了结姿态。本季共减仓 21 个仓位并完全清仓 14 档持股，调降曝光的仓位数量高于加仓动作。
在资产配置集中度方面，Redmile Group, LLC 的前 5 大核心持股（包含 KRYS, AM6, NRIX 等）合计占整体申报市值的 34.1%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | KRYS | Krystal Biotech Inc | 股票-医疗保健 | 11.34% | +4.25% | -32.30% | |
| 2 | AM6 | Amicus Therapeutics Inc | 股票-其他 | 6.35% | — | -20.08% | |
| 3 | NRIX | Nurix Therapeutics Inc | 股票-其他 | 5.58% | -1.30% | -1.32% | |
| 4 | STOK | Stoke Therapeutics Inc | 股票-其他 | 3.86% | -0.31% | -6.94% | |
| 5 | IMNM | Immunome Inc | 股票-其他 | 3.58% | -1.06% | — | |
| 6 | RGNX | Regenxbio Inc | 股票-其他 | 3.23% | +1.09% | +0.40% | |
| 7 | LIVN | LivaNova PLC | 股票-其他 | 3.08% | +0.05% | -10.43% | |
| 8 | REPL | Replimune Group Inc | 股票-其他 | 3.03% | — | +49.12% | |
| 9 | ✓ | Adc Therapeutics SA | 股票-其他 | 2.92% | -3.01% | — | |
| 10 | KYMR | Kymera Therapeutics Inc | 股票-其他 | 2.85% | — | -8.93% | |
| 11 | SRRK | Scholar Rock Holding CORP | 股票-其他 | 2.75% | -13.59% | -15.06% | |
| 12 | ZYME | Zymeworks Inc | 股票-其他 | 2.68% | +0.04% | -6.29% | |
| 13 | FATE | Fate Therapeutics Inc | 股票-其他 | 2.61% | +1.31% | — | |
| 14 | COGT | Cogent Biosciences Inc | 股票-其他 | 2.45% | -0.44% | +21.13% | |
| 15 | BEAM | Beam Therapeutics Inc | 股票-其他 | 2.41% | +0.73% | -9.39% | |
| 16 | SLN | Silence Therapeutics Plc-adr | 股票-其他 | 2.31% | +0.84% | -0.66% | |
| 17 | AKRO | Akero Therapeutics Inc | 股票-其他 | 2.29% | — | -13.14% | |
| 18 | BHVN | Biohaven Ltd. | 股票-其他 | 2.28% | — | -6.50% | |
| 19 | NGNE | Neurogene Inc | 股票-其他 | 2.23% | +1.03% | +8.38% | |
| 20 | PLRX | Pliant Therapeutics Inc | 股票-其他 | 2.09% | — | +3.63% | |
| 21 | CTLTEUR | Catalent Inc | 股票-其他 | 2.02% | — | -5.83% | |
| 22 | ANNX | Annexon Inc | 股票-其他 | 1.90% | -0.79% | +16.80% | |
| 23 | BSX | Boston Scientific CORP | 股票-医疗保健 | 1.82% | — | -30.43% | |
| 24 | IDYA | Ideaya Biosciences Inc | 股票-其他 | 1.61% | +0.45% | -17.68% | |
| 25 | CLDX | Celldex Therapeutics Inc | 股票-其他 | 1.61% | +0.53% | -19.83% | |
| 26 | ABSI | Absci CORP | 股票-其他 | 1.54% | +3.60% | — | |
| 27 | KROS | Keros Therapeutics Inc | 股票-其他 | 1.53% | — | — | |
| 28 | ALXO | Alx Oncology Holdings Inc | 股票-其他 | 1.47% | -0.03% | -6.70% | |
| 29 | FDMT | 4d Molecular Therapeutics In | 股票-其他 | 1.36% | — | -14.90% | |
| 30 | STTK | Shattuck Labs Inc | 股票-其他 | 1.31% | +0.85% | — | |
| 31 | 1K0 | Igm Biosciences Inc | 股票-其他 | 1.28% | — | — | |
| 32 | IMVT | Immunovant Inc | 股票-其他 | 1.15% | — | -25.73% | |
| 33 | ISRG | Intuitive Surgical Inc | 股票-医疗保健 | 1.07% | — | +34.85% | |
| 34 | AUGX | Augmedix Inc | 股票-其他 | 0.87% | — | — | |
| 35 | ETNBGBP | 89bio Inc | 股票-其他 | 0.85% | — | -22.91% | |
| 36 | ARDX | Ardelyx Inc | 股票-其他 | 0.84% | -0.07% | -14.27% | |
| 37 | SYK | Stryker CORP | 股票-医疗保健 | 0.81% | — | -8.70% | |
| 38 | PRME | Prime Medicine Inc | 股票-其他 | 0.64% | -0.03% | — | |
| 39 | 2655787D | Blueprint Medicines CORP | 股票-其他 | 0.62% | — | -16.50% | |
| 40 | ✓ | Establishment Labs Holdings In | 股票-其他 | 0.59% | +0.12% | +86.31% | |
| 41 | NUVB | Nuvation Bio Inc | 股票-其他 | 0.54% | +0.26% | — | |
| 42 | TRDA | Entrada Therapeutics Inc | 股票-其他 | 0.48% | — | -56.30% | |
| 43 | ACIU | AC Immune SA | 股票-其他 | 0.44% | — | -9.93% | |
| 44 | ✓ | Verve Therapeutics Inc | 股票-其他 | 0.43% | — | -8.79% | |
| 45 | RPTX | Repare Therapeutics Inc | 股票-其他 | 0.39% | — | -3.66% | |
| 46 | CYTK | Cytokinetics Inc | 股票-医疗保健 | 0.37% | — | -30.78% | |
| 47 | VTYXUSD | Ventyx Biosciences Inc | 股票-其他 | 0.30% | — | — | |
| 48 | BOLD | Boundless Bio Inc | 股票-其他 | 0.24% | — | -7.13% | |
| 49 | ATRA | Atara Biotherapeutics Inc | 股票-其他 | 0.23% | +0.20% | — | |
| 50 | STXS | Stereotaxis Inc | 股票-其他 | 0.23% | — | -36.28% |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | NRIX | Nurix Therapeutics Inc | +3.2% | -1.32% | 减仓 |
| 2 | REPL | Replimune Group Inc | +1.9% | +49.12% | 加仓 |
| 3 | KRYS | Krystal Biotech Inc | +1.5% | -32.30% | 减仓 |
| 4 | COGT | Cogent Biosciences Inc | +1.5% | +21.13% | 加仓 |
| 5 | LIVN | LivaNova PLC | +1% | -10.43% | 减仓 |
| 6 | AM6 | Amicus Therapeutics Inc | +0.6% | -20.08% | 减仓 |
| 7 | AKRO | Akero Therapeutics Inc | +0.6% | -13.14% | 减仓 |
| 8 | ZYME | Zymeworks Inc | +0.5% | -6.29% | 减仓 |
| 9 | NGNE | Neurogene Inc | +0.5% | +8.38% | 加仓 |
| 10 | ANNX | Annexon Inc | +0.5% | +16.80% | 加仓 |
| 11 | BSX | Boston Scientific CORP | +0.4% | -30.43% | 减仓 |
| 12 | ✓ | Adc Therapeutics SA | +0.4% | — | 不变 |
| 13 | PLRX | Pliant Therapeutics Inc | +0.4% | +3.63% | 加仓 |
| 14 | KYMR | Kymera Therapeutics Inc | +0.3% | -8.93% | 减仓 |
| 15 | CLDX | Celldex Therapeutics Inc | +0.2% | -19.83% | 减仓 |
| 16 | KROS | Keros Therapeutics Inc | +0.2% | — | 不变 |
| 17 | 1K0 | Igm Biosciences Inc | +0.2% | — | 不变 |
| 18 | BEAM | Beam Therapeutics Inc | +0.1% | -9.39% | 减仓 |
| 19 | IDYA | Ideaya Biosciences Inc | +0.1% | -17.68% | 减仓 |
| 20 | IMVT | Immunovant Inc | — | -25.73% | 减仓 |
| 21 | BHVN | Biohaven Ltd. | -0.1% | -6.50% | 减仓 |
| 22 | FDMT | 4d Molecular Therapeutics In | -0.1% | -14.90% | 减仓 |
| 23 | ETNBGBP | 89bio Inc | -0.1% | -22.91% | 减仓 |
| 24 | VTYXUSD | Ventyx Biosciences Inc | -0.1% | — | 不变 |
| 25 | ABSI | Absci CORP | -0.2% | — | 不变 |
| 26 | TRDA | Entrada Therapeutics Inc | -0.2% | -56.30% | 减仓 |
| 27 | RGNX | Regenxbio Inc | -0.3% | +0.40% | 加仓 |
| 28 | ALXO | Alx Oncology Holdings Inc | -0.3% | -6.70% | 减仓 |
| 29 | APLSUSD | Apellis Pharmaceuticals Inc | -0.3% | EXIT | 清仓 |
| 30 | BOLD | Boundless Bio Inc | -0.3% | -7.13% | 减仓 |
| 31 | ✓ | Verve Therapeutics Inc | -0.4% | -8.79% | 减仓 |
| 32 | 2JQ | Gritstone Bio Inc | -0.4% | -11.25% | 减仓 |
| 33 | PEN | Penumbra Inc | -0.4% | EXIT | 清仓 |
| 34 | ELAN | Elanco Animal Health Inc | -0.4% | EXIT | 清仓 |
| 35 | DGX | Quest Diagnostics Inc | -0.4% | EXIT | 清仓 |
| 36 | MCK | Mckesson CORP | -0.4% | EXIT | 清仓 |
| 37 | PGNY | Progyny Inc | -0.5% | EXIT | 清仓 |
| 38 | ICLR | ICON Public Limited Company | -0.5% | EXIT | 清仓 |
| 39 | STTK | Shattuck Labs Inc | -0.5% | — | 不变 |
| 40 | ELV | Elevance Health Inc | -0.6% | EXIT | 清仓 |
| 41 | HCA | Hca Healthcare Inc | -0.6% | EXIT | 清仓 |
| 42 | EVH | Evolent Health Inc - A | -0.8% | EXIT | 清仓 |
| 43 | IMNM | Immunome Inc | -0.9% | — | 不变 |
| 44 | CI | THE Cigna Group | -0.9% | EXIT | 清仓 |
| 45 | FATE | Fate Therapeutics Inc | -0.9% | — | 不变 |
| 46 | ALGN | Align Technology Inc | -1.1% | EXIT | 清仓 |
| 47 | ABT | Abbott Laboratories | -1.1% | EXIT | 清仓 |
| 48 | SRRK | Scholar Rock Holding CORP | -1.4% | -15.06% | 减仓 |
| 49 | AUGX | Augmedix Inc | -1.6% | — | 不变 |
| 50 | DCPHEUR | Deciphera Pharmaceuticals In | -3.1% | EXIT | 清仓 |
根据 SEC 官方 Form 13F 申报备案，Redmile Group, LLC 在 Q2 2024 季度的美股持仓总市值约为 US$14.9亿，共申报了 63 个公开持股仓位。
在 Q2 2024 季度，Redmile Group, LLC 按市值排列的前三大核心持股分别为：KRYS (11.3%)、AM6 (6.3%)、NRIX (5.6%)。其中最大持股仓位 KRYS 占据整体投资组合约 11.3% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大获利了结 / 清仓标的
DCPHEUR
前期市值: US$8331.6万
在 Q2 2024 季度中，Redmile Group, LLC 共进行了 41 项持仓异动，包含新建仓 0 个仓位、加仓 6 个仓位、减仓 21 个仓位以及清仓 14 个仓位。 本季清仓仓位包含 DCPHEUR。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。